The main goal of this meeting was to gather experimental researchers, physicians and epidemiologists working in the fields of molecular and clinical microbiology as well as host-pathogen interaction.
More than 130 scientists from Germany, Czech Republic, and the Swedisch Universities in Uppsala, Gothenburg, Stockholm, Lund, and Umeå participated. 13 Biotech companies participated as exhibitors.
Mainly postdocs and PhD students had the opportunity to present their research in a talk or a poster. The technical platforms from Umeå University which are involved in infection research participated during the poster session on Thursday afternoon.
ORGANISING COMMITTEE and contact persons
pictures from the meeting
The national infection biology meetings (NIBM) from 2005 - 2011
The first meeting of its kind was a closing event of a large research network fund by the Swedish Foundation for Strategic Research. The meeting was held in 2005 in Linköping and was meant to gather all research partners of the network together to initiate further cooperation.
At that time it was agreed to continue these meetings annually on a nation-wide level. To organize these meetings funding was received from the Swedish Research Council.
The second meeting was held in 2006 in Umeå. The third meeting took place 2007 in Uppsala and the 4th 2008 in Malmö. The meetings were in general very well accepted and attracted each time more than 100 researchers working in the field of infection biology.
In 2009 the Symposium on Bacterial Cell Biology and Pathogenesis was organized in Umeå with international guests and key note lecturers and thus substituted the traditional NIB meeting in this year. From then on the meeting was planed to be held biannually.
Therefore the next NIB meeting will take place 2011 in Umeå. Main organizer for the meeting is the newly founded Laboratory for Molecular Infection Medicine Sweden (MIMS). By organizing this meeting The Nordic Node of the EMBL partnership in Sweden that exists since 2007 and has sister laboratories in Helsinki (FIMM) and Oslo (NCMM) underlines its role as a national centre for infection and molecular medicine in Sweden.